Patient-perceived harm and side effects of medication
Related entities
Findings (27)
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia
None
adverseAbout one in three patients with diabetes expected their glucose-lowering medications to cause frequent hypoglycemia (29.4%) and additional harm (33%), with 28.4% believing side effects were unavoidab
Effect: adverse; 29.4% expected frequent hypoglycemia; 33% expected additional harm beyond hypoglycemia